Overview


According to FutureWise analysis the market for animal drugs in 2023 is US$ 36.97 billion, and is expected to reach US$ 57.25 billion by 2031 at a CAGR of 5.60%.

Animal drugs, also known as veterinary pharmaceuticals or veterinary drugs, are specialized substances designed to prevent, diagnose, treat, or mitigate diseases, injuries, or other health conditions in animals. These drugs are developed to cater to various animal species' specific physiological and metabolic needs, including pets, livestock, wildlife, and laboratory animals. Animal drugs consist of a wide range of formulations, including oral medications (tablets, capsules, liquids), topical treatments (creams, ointments, sprays), injectables, and even, in some cases, medicated feed additives. These must be prescribed by licensed veterinarians, administered by animal owners under veterinary guidance, or used in specific agricultural and research settings. These drugs are formulated to address various health concerns in animals. This includes antibiotics to fight against bacterial infections, vaccines for disease prevention, antiparasitic to control parasites like fleas, ticks, and worms, analgesics, and anti-inflammatories to manage pain and inflammation, and various specialized medications for conditions ranging from cardiovascular diseases to behavioural issues. these drugs are also developed for the reproductive health of the animals, helping them in breeding programs and supporting fertility. Some hormonal treatments are also given to induce ovulation and regulate the oestrus cycle.

The development and approval of animal drugs involve rigorous testing and regulatory processes to ensure their safety, efficacy, and suitability for use in specific species. The use of animal drugs is guided by veterinary professionals who assess the animal's health condition, consider potential drug interactions, and provide dosage instructions.

FutureWise Market Research has published a report that provides an insightful analysis of Animal Drugs Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Animal Drugs Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Zoetis
  • Boehringer Ingelheim
  • Bayer
  • Elanco Animal Health
  • Ceva
  • Dechra
  • Merck
  • Virbac
  • Vetoquinol
  • Archer Daniels Midland

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Animal Drugs Market:

  • In April of 2022, Elanco Animal Health Incorporated and Ginkgo Bioworks joined forces to introduce BiomEdit, a pioneering microbiome innovation enterprise. This collaborative venture is focused on the development and commercialization of groundbreaking products such as probiotics, bioactive compounds, specially engineered microbial therapeutics, and monitoring services, all geared towards enhancing animal health.
  • Additionally, in January 2022, the United States Food and Drug Administration granted approval for Solensia (frunevetmab injection) by Zoetis, marking a significant milestone in the treatment of osteoarthritis pain in cats.

Several factors drive the animal drug market. There is a trend of keeping pets in the house, and the rise in pet ownership caused by factors like companionship and emotional well-being leads to higher demand for veterinary and pet care products. One such is animal drugs and therapeutics; this is driving the market. Increasing awareness about animal health and welfare benefits drives pet owners and livestock producers to seek advanced healthcare solutions and preventive measures for their animals. Ongoing research and technological advancement in veterinary medicine and treatments lead to the development of more advanced interventions, therapies, therapeutics, and diagnostic tools, thus propelling the market.to safeguard public health, which is affected by the zoonotic disease caused by animals, it is necessary to take care of animal health by administration of animal drugs to prevent any complications and, in turn, public health. With the increasing population, the demand for products such as dairy, meat, and eggs necessitates animal health and indulgence of animal drugs so as to prevent them from any disease and fuel market growth.
 
However, there are significant restraints that are affecting the market growth. The high cost of advanced treatment is one of the major ones where veterinary medicine and therapeutics are very costly and thus becomes a barrier for pet owners and livestock producers to rely on these, hence depleting the market.in some remote areas, there may be less accessibility to these veterinary services, like the availability of animal drugs, which hinders the timely and effective treatment of the animals, thus hampering the market growth. 

By Product Type

  • Drugs
    • Anti-infective
    • Anti-inflammatory
    • Parasiticide
  • Vaccines
    • Inactivated Vaccines
    • Attenuated Vaccines
    • Recombinant Vaccines
  • Medicated Feed Additives
    • Amino Acids
    • Antibiotics

By Route of Administration

  • Oral Route
  • Parenteral Route
  • Topical Route

By Animal Type

  • Companion Animals
  • Livestock Animals

By Distribution Channel

  • Veterinary Hospital Pharmacies
  • Retail Veterinary Pharmacies

By Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America held the largest market share due to the rise in the prevalence of diseases in pets and animals, well-established animal healthcare infrastructure, early adoption of technological advancements in the animals and drug therapeutics, high animal healthcare expenditure, and implementation of definitive measures by the government for animal welfare organizations constantly working to aid in better overall animal health. Furthermore, rising zoonotic disease incidence and increasing number of pet owners are expected to propel the market expansion in this region. In addition, government initiatives are playing a significant role in raising funds and promoting advanced healthcare technologies and research and development for animal drugs and therapeutics, which is propelling the market in this region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the of Animal Drugs Market By Product Type, By Route of Administration, By Animal Type, By Distribution Channel and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections, which are represented in the format of data sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors, which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Animal Drugs Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Animal Drugs Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Animal Drugs Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Animal Drugs Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Drugs
         1.1. Anti-infective
         1.2. Anti-inflammatory
         1.3. Parasiticide
        2. Vaccines
         2.1. Inactivated Vaccines
         2.2. Attenuated Vaccines
         2.3. Recombinant Vaccines
        3. Medicated Feed Additives
         3.1. Amino Acids
         3.2. Antibiotics

  • 8.   Animal Drugs Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral Route
        2. Parenteral Route
        3. Topical Route

  • 9.   Animal Drugs Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Companion Animals
        2. Livestock Animals

  • 10.   Animal Drugs Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Veterinary Hospital Pharmacies
        2. Retail Veterinary Pharmacies

  • 11.   North America Animal Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Animal Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Animal Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Animal Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Zoetis
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Boehringer Ingelheim
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Bayer
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Elanco Animal Health
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Ceva
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Dechra
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Merck
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Virbac
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Vetoquinol
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Archer Daniels Midland
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Related Market

Animal Drug Compounding Market

Read More
Partner

Our Clients